Maria Pia Brizzi

Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression.

A. Scarpa, M. Falconi, N. Fazio, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.

C. Porta, G. Banna, U. de Giorgi, 2014, Future oncology.

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.

C. Porta, G. Banna, U. de Giorgi, 2014, Future Oncology.